Prot# A3871022: A Phase 2b, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Dose Response Study to Assess the Efficacy and Safety of Oral UK-390,957 in Men with Premature Ejaculation

Project: Research project

Project Details

StatusFinished
Effective start/end date3/28/05 → 6/28/05

Funding

  • Pfizer Inc. (A3871022)